Multi-targeted quinoline-sulfonamide-chalcone hybrids: novel candidates for anti-quorum sensing, anti-biofilm, and anticancer activities
Küçük Resim Yok
Tarih
2026
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Academic Press Inc Elsevier Science
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
This study presents the rational design, synthesis, and comprehensive evaluation of a novel series of quinolinesulfonamide-chalcone (QCSa-i) hybrids as potential multi-targeted therapeutic agents. By a hybridization approach, the series was investigated for the antimicrobial, anti-quorum sensing, antibiofilm, and anticancer activities, complemented by extensive in silico analyses including (DFT) calculations and molecular docking simulations against key oncogenic targets (Bcl-2, EGFR, Survivin), alongside ADME profiling. The studied compounds demonstrated promising biological activities, with QCS-h emerging as a lead candidate exhibiting broad-spectrum antimicrobial activity against both B. cereus, P. aeruginosa, and C. glabrata, with considerably lower IC50 values compared to the used standards, tetracycline and nystatin. Furthermore, QCS-h demonstrated superior antibiofilm activity, achieving over 80% inhibition against strong biofilm-forming Escherichia coli at all tested concentrations. Molecular docking studies revealed the QCS-h's remarkable binding affinity for the Epidermal Growth Factor Receptor (EGFR), with a binding energy of -11.25 kcal/mol and a theoretical inhibition constant of 5.68 nM, significantly outperforming the control compound (1.85 mu M). DFT calculations provided insights into the electronic properties, facilitating the understanding of the wet experiments. The favorable ADME profiles further support the drug-like potential of these compounds. This integrative approach highlights the therapeutic promise of quinoline-sulfonamide-chalcone hybrids, particularly QCS-h, as multitargeted agents for combating antimicrobial resistance and gastrointestinal malignancies, providing valuable insights for future rational drug design strategies.
Açıklama
Anahtar Kelimeler
[Keyword Not Available]
Kaynak
Bioorganic Chemistry
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
173












